關於 VACCINOGEN INC
Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy called OncoVAX, where a patient's own tumor cells are used as the vaccine, adjuvanted by BCG. This product was evaluated in Phase III in colon cancer in the 1990s and another Phase III study, called ACTIVE, is currently recruiting stage II colon cancer patients. Vaccinogen calls its approach 'Active Specific Immunotherapy' or ASI.
Source: Wikipedia
產業Biotechnology
總部Frederick, MD
成立時間2007
法律形式C Corporation
狀態營運中
關鍵數據
法律資訊
| 法定名稱 | VACCINOGEN INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1453001在 SEC EDGAR 上查看 ↗ |
| 登記地址 | Frederick, MD |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年11月14日